Literature DB >> 23908464

Genetic loss of SH2B3 in acute lymphoblastic leukemia.

Arianne Perez-Garcia1, Alberto Ambesi-Impiombato, Michael Hadler, Isaura Rigo, Charles A LeDuc, Kara Kelly, Chaim Jalas, Elisabeth Paietta, Janis Racevskis, Jacob M Rowe, Martin S Tallman, Maddalena Paganin, Giuseppe Basso, Wei Tong, Wendy K Chung, Adolfo A Ferrando.   

Abstract

The SH2B adaptor protein 3 (SH2B3) gene encodes a negative regulator of cytokine signaling with a critical role in the homeostasis of hematopoietic stem cells and lymphoid progenitors. Here, we report the identification of germline homozygous SH2B3 mutations in 2 siblings affected with developmental delay and autoimmunity, one in whom B-precursor acute lymphoblastic leukemia (ALL) developed. Mechanistically, loss of SH2B3 increases Janus kinase-signal transducer and activator of transcription signaling, promotes lymphoid cell proliferation, and accelerates leukemia development in a mouse model of NOTCH1-induced ALL. Moreover, extended mutation analysis showed homozygous somatic mutations in SH2B3 in 2 of 167 ALLs analyzed. Overall, these results demonstrate a Knudson tumor suppressor role for SH2B3 in the pathogenesis of ALL and highlight a possible link between genetic predisposition factors in the pathogenesis of autoimmunity and leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23908464      PMCID: PMC3790510          DOI: 10.1182/blood-2013-05-500850

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

Review 1.  Lnk adaptor: novel negative regulator of B cell lymphopoiesis.

Authors:  C E Rudd
Journal:  Sci STKE       Date:  2001-06-05

2.  Comparative gene marker selection suite.

Authors:  Joshua Gould; Gad Getz; Stefano Monti; Michael Reich; Jill P Mesirov
Journal:  Bioinformatics       Date:  2006-05-18       Impact factor: 6.937

3.  Sotos syndrome is associated with leukemia/lymphoma.

Authors:  Víctor Martínez-Glez; Pablo Lapunzina
Journal:  Am J Med Genet A       Date:  2007-06-01       Impact factor: 2.802

4.  Use of a simple method for the Epstein-Barr virus transformation of lymphocytes from members of large families of Réunion Island.

Authors:  M Ventura; A Gibaud; J Le Pendu; D Hillaire; G Gérard; D Vitrac; R Oriol
Journal:  Hum Hered       Date:  1988       Impact factor: 0.444

5.  Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins.

Authors:  S Takaki; K Sauer; B M Iritani; S Chien; Y Ebihara; K Tsuji; K Takatsu; R M Perlmutter
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

6.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

7.  Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction.

Authors:  Jun Seita; Hideo Ema; Jun Ooehara; Satoshi Yamazaki; Yuko Tadokoro; Akiko Yamasaki; Koji Eto; Satoshi Takaki; Kiyoshi Takatsu; Hiromitsu Nakauchi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

8.  Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase.

Authors:  X Huang; Y Li; K Tanaka; K G Moore; J I Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk.

Authors:  Satoshi Takaki; Hatsue Morita; Yoshinari Tezuka; Kiyoshi Takatsu
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

10.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.

Authors:  W S Pear; J C Aster; M L Scott; R P Hasserjian; B Soffer; J Sklar; D Baltimore
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  53 in total

1.  SH2B3: a new leukemia predisposition gene.

Authors:  Cheryl L Willman
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

2.  TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Maoxiang Qian; Xueyuan Cao; Meenakshi Devidas; Wenjian Yang; Cheng Cheng; Yunfeng Dai; Andrew Carroll; Nyla A Heerema; Hui Zhang; Takaya Moriyama; Julie M Gastier-Foster; Heng Xu; Elizabeth Raetz; Eric Larsen; Naomi Winick; W Paul Bowman; Paul L Martin; Elaine R Mardis; Robert Fulton; Gerard Zambetti; Michael Borowitz; Brent Wood; Kim E Nichols; William L Carroll; Ching-Hon Pui; Charles G Mullighan; William E Evans; Stephen P Hunger; Mary V Relling; Mignon L Loh; Jun J Yang
Journal:  J Clin Oncol       Date:  2018-01-04       Impact factor: 44.544

Review 3.  Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui
Journal:  Front Med       Date:  2014-12-15       Impact factor: 4.592

Review 4.  Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.

Authors:  Yoshihiro Gocho; Jun J Yang
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

Review 5.  Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine.

Authors:  Stephen P Hunger; Charles G Mullighan
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

Review 6.  12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?

Authors:  Georg Auburger; Suzana Gispert; Suna Lahut; Ozgür Omür; Ewa Damrath; Melanie Heck; Nazlı Başak
Journal:  World J Diabetes       Date:  2014-06-15

Review 7.  Genetic susceptibility in childhood acute lymphoblastic leukemia.

Authors:  Angela Gutierrez-Camino; Idoia Martin-Guerrero; Africa García-Orad
Journal:  Med Oncol       Date:  2017-09-13       Impact factor: 3.064

8.  Genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Authors:  Fredrick R Schumacher; Stephanie L Schmit; Shuo Jiao; Christopher K Edlund; Hansong Wang; Ben Zhang; Li Hsu; Shu-Chen Huang; Christopher P Fischer; John F Harju; Gregory E Idos; Flavio Lejbkowicz; Frank J Manion; Kevin McDonnell; Caroline E McNeil; Marilena Melas; Hedy S Rennert; Wei Shi; Duncan C Thomas; David J Van Den Berg; Carolyn M Hutter; Aaron K Aragaki; Katja Butterbach; Bette J Caan; Christopher S Carlson; Stephen J Chanock; Keith R Curtis; Charles S Fuchs; Manish Gala; Edward L Giovannucci; Stephanie M Gogarten; Richard B Hayes; Brian Henderson; David J Hunter; Rebecca D Jackson; Laurence N Kolonel; Charles Kooperberg; Sébastien Küry; Andrea LaCroix; Cathy C Laurie; Cecelia A Laurie; Mathieu Lemire; David Levine; Jing Ma; Karen W Makar; Conghui Qu; Darin Taverna; Cornelia M Ulrich; Kana Wu; Suminori Kono; Dee W West; Sonja I Berndt; Stéphane Bezieau; Hermann Brenner; Peter T Campbell; Andrew T Chan; Jenny Chang-Claude; Gerhard A Coetzee; David V Conti; David Duggan; Jane C Figueiredo; Barbara K Fortini; Steven J Gallinger; W James Gauderman; Graham Giles; Roger Green; Robert Haile; Tabitha A Harrison; Michael Hoffmeister; John L Hopper; Thomas J Hudson; Eric Jacobs; Motoki Iwasaki; Sun Ha Jee; Mark Jenkins; Wei-Hua Jia; Amit Joshi; Li Li; Noralene M Lindor; Keitaro Matsuo; Victor Moreno; Bhramar Mukherjee; Polly A Newcomb; John D Potter; Leon Raskin; Gad Rennert; Stephanie Rosse; Gianluca Severi; Robert E Schoen; Daniela Seminara; Xiao-Ou Shu; Martha L Slattery; Shoichiro Tsugane; Emily White; Yong-Bing Xiang; Brent W Zanke; Wei Zheng; Loic Le Marchand; Graham Casey; Stephen B Gruber; Ulrike Peters
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

Review 9.  The function of SH2B3 (LNK) in the kidney.

Authors:  Gregory Blass; David L Mattson; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20

10.  LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.

Authors:  Ying Cheng; Kudakwashe Chikwava; Chao Wu; Haibing Zhang; Anchit Bhagat; Dehua Pei; John K Choi; Wei Tong
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.